Your browser doesn't support javascript.
loading
Multisystem inflammatory syndrome in adults: A rare sequela of SARS-CoV-2 infection.
Ahmad, Faran; Ahmed, Arslan; Rajendraprasad, Sanu S; Loranger, Austin; Gupta, Sonia; Velagapudi, Manasa; Vivekanandan, Renuga; Nahas, Joseph A; Plambeck, Robert; Moore, Douglas.
Afiliação
  • Ahmad F; Creighton University Medical Center - Bergan Mercy, 7500 Mercy Road, Omaha, NE 68124, USA. Electronic address: faranahmad@creighton.edu.
  • Ahmed A; Creighton University Medical Center - Bergan Mercy, 7500 Mercy Road, Omaha, NE 68124, USA.
  • Rajendraprasad SS; Creighton University Medical Center - Bergan Mercy, 7500 Mercy Road, Omaha, NE 68124, USA.
  • Loranger A; Creighton University Medical Center - Bergan Mercy, 7500 Mercy Road, Omaha, NE 68124, USA.
  • Gupta S; Creighton University Medical Center - Bergan Mercy, 7500 Mercy Road, Omaha, NE 68124, USA.
  • Velagapudi M; Creighton University Medical Center - Bergan Mercy, 7500 Mercy Road, Omaha, NE 68124, USA.
  • Vivekanandan R; Creighton University Medical Center - Bergan Mercy, 7500 Mercy Road, Omaha, NE 68124, USA; Creighton University, School of Medicine, Omaha, NE 68178, USA; Dr C.C. and Mabel L. Criss Health Sciences Complex II, 2621 Burt Street, Omaha, NE 68178, USA.
  • Nahas JA; Creighton University Medical Center - Bergan Mercy, 7500 Mercy Road, Omaha, NE 68124, USA.
  • Plambeck R; Creighton University Medical Center - Bergan Mercy, 7500 Mercy Road, Omaha, NE 68124, USA.
  • Moore D; Creighton University Medical Center - Bergan Mercy, 7500 Mercy Road, Omaha, NE 68124, USA.
Int J Infect Dis ; 108: 209-211, 2021 Jul.
Article em En | MEDLINE | ID: mdl-34044140
Multisystem inflammatory syndrome in adults (MIS-A) came to attention back in June 2020, when the United States Center for Disease Control and Prevention (CDC) received initial reports regarding patients who had presented delayed and multisystem involvement of the disease, with clinical course resembling multisystem inflammatory syndrome in children (MIS-C). This study introduces a case of MIS-A, where the patient presented 3 weeks after initial COVID-19 exposure. His clinical course was consistent with the working definition of MIS-A as specified by the CDC. Aggressive supportive care in the intensive care unit, utilization of advanced heart failure devices, and immunomodulatory therapeutics (high-dose steroids, anakinra, intravenous immunoglobulin) led to clinical recovery. Management of MIS-A is a topic of ongoing research and needs more studies to elaborate on treatment modalities and clinical predictors.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Prognostic_studies Limite: Adult / Child / Humans País como assunto: America do norte Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Prognostic_studies Limite: Adult / Child / Humans País como assunto: America do norte Idioma: En Ano de publicação: 2021 Tipo de documento: Article